Results 171 to 180 of about 16,223 (208)
Some of the next articles are maybe not open access.
Progressive supranuclear Palsy
Archiv f�r Psychiatrie und Nervenkrankheiten, 1971Es wird uber eine Beobachtung von „progressive supranuclear palsy“ berichtet, bei der die Erkrankung etwa mit 12 Jahren begann, uber 23 Jahre hin langsam progressiv verlief und die klinisch im wesentlichen durch eine parkinsonistische Symptomatik ausgezeichnet war. Anatomisch fand sich neben einer schweren Degeneration der S.
openaire +2 more sources
PROGRESSIVE SUPRANUCLEAR PALSY
Medical Clinics of North America, 1999Richardson observed an unusual clinical syndrome in the 1950s, which he later designated progressive supranuclear palsy (PSP). Over the past 25 years, although knowledge of this disorder has gradually improved, its cause is still unknown, pathogenesis is unclear, and there is still no definitive treatment for this disorder.
openaire +2 more sources
Pain in Progressive Supranuclear Palsy
Clinical Neuropharmacology, 2009We describe a patient with progressive supranuclear palsy who presented with a major complaint of neck pain. The pain was alleviated when given lidocaine intravenously. Response was maintained for an extended period. Lidocaine should be considered in pain relief of dystonia to improve quality of life.
Ilana, Schlesinger +2 more
openaire +2 more sources
Pramipexole in progressive supranuclear palsy
Neurology, 1999Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder with no effective treatment. Dopaminergic agents occasionally produce transient symptomatic improvement. The authors report the results of pramipexole treatment (4.5 mg daily) in six patients with PSP (average disease duration, 4.4 years).
W J, Weiner, A, Minagar, L M, Shulman
openaire +2 more sources
Vascular progressive supranuclear palsy
1994Progressive supranuclear palsy (PSP) is a neurologic syndrome of unknown cause. This idiopathic type of PSP is usually associated with characteristic clinical and pathological features.To assess evidence of cerebrovascular disease in a population of patients with clinically defined PSP, and to compare clinical and neuroimaging features in vascular ...
J, Winikates, J, Jankovic
openaire +2 more sources
Hyposmia in progressive supranuclear palsy
Movement Disorders, 2010AbstractPrevious studies suggested that olfaction is normal in progressive supranuclear palsy (PSP). We applied the University of Pennsylvania Smell Identification Test (UPSIT) to 36 patients with PSP who scored more than 18 on the Mini Mental State Examination (MMSE), 140 patients with nondemented Parkinson's disease (PD) and 126 controls.
Silveira-Moriyama L +11 more
openaire +3 more sources
Progressive supranuclear palsy on Guam
Acta Neuropathologica, 2001This is the first report demonstrating that progressive supranuclear palsy (PSP) exists on Guam. This 75-year-old Guamanian Chamorro patient with slight dementia and rigidity with restriction of ocular up gaze was diagnosed as parkinsonism-dementia complex (PDC) of Guam clinically.
M, Yamazaki +6 more
openaire +2 more sources
Caregiving in progressive supranuclear palsy
Neurology, 1998Basic issues regarding factors influencing progressive supranuclear palsy (PSP) patient caregiver burden remain unresolved, including whether and how disease severity and duration influence caregiver burden.To examine the relation between PSP patient caregiver burden and disease severity, describe the time course of caregiver burden in relation to ...
B, Uttl +3 more
openaire +2 more sources
Tremor in progressive supranuclear palsy
Acta Neurologica Scandinavica, 1989Reports of tremor in progressive supranuclear palsy (PSP) have been infrequent; some authors indicate that tremor is never seen in PSP. Five patients with PSP and tremor are presented. Our series of cases and those reviewed in the literature suggest that tremor occurs in 12-16% of PSP cases. The rest tremor observed in 3 of our cases differed from the "
E F, Masucci, J F, Kurtzke
openaire +2 more sources
Genetics of progressive supranuclear palsy
2008Publisher Summary This chapter emphasizes that progressive supranuclear palsy (PSP) is the second most common form of degenerative parkinsonism and is characterized clinically by an akinetic-rigid syndrome, supranuclear gaze palsy, pseudobulbar signs, and cognitive decline of frontal lobe type.
Alan, Pittman +3 more
openaire +2 more sources

